Topic:
Partnering
Latest Headlines
Latest Headlines
Eli Lilly, Corgenix ink cancer drug companion Dx deal
Eli Lilly will work with Corgenix Medical to develop companion diagnostics for its cancer drug pipeline.
Stryker, OrthoSensor renew knee replacement co-marketing agreement
Stryker and OrthoSensor extended their agreement to co-market Stryker's Triathlon knee system and OrthoSensor's Verasense feedback instrument for knee-replacement surgery.
GlaxoSmithKline wins up to $200M federal contract to develop new antibiotics
In the first collaboration of its kind, the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority has brought on GlaxoSmithKline to help the federal agency develop new antibiotics to combat bioterrorism and growing resistance to the drugs.
Nordion inks CMO deal with Navidea
Navidea Biopharmaceuticals has seen its fair share of CMO troubles, as problems with its last contract manufacturer delayed a much-anticipated FDA approval. Now, the diagnostics developer is hitching up with Nordion to manufacture an in-development imaging agent, hoping to avoid more production setbacks.
AbbVie, Galapagos extend JAK1 pact into Crohn's disease with $50M carrot
The North Chicago, IL-based drug giant and Belgium's Galapagos have agreed to expand their collaboration on an oral JAK1 inhibitor to include Crohn's disease.
Amgen, Novartis aim to fuel biotech startups in alliances with Atlas Venture
For Amgen and Novartis, investing in the latest fund from Atlas Venture wasn't enough. The Cambridge, MA-based venture firm has struck separate agreements with the two major drugmakers to join forces on biotech startups.
Quintiles signs on to help Merck KGaA right the R&D ship
Amid repeated pipeline struggles and an R&D re-think, Merck KGaA has signed an exclusive deal with the newly public Quintiles, launching a novel collaboration that will give the CRO a seat at the decisionmaking table.
Quintiles joins Merck KGaA's R&D command post in 5-year exclusive
In the pact, investigators at Merck Serono will join hands with experts at Quintiles to shape and guide the company's R&D strategy while the CRO manages trial planning and execution from Phase I through post-marketing studies.
Cash injection raises hopes of diabetes vaccine
An alliance between supermarket chain Tesco and charity Diabetes UK has brought renewed optimism in the pursuit of a vaccine for Type 1 diabetes.
Cempra snags $70M antibiotic pact with Japan's Toyama
Toyama Chemical, a subsidiary of FujiFilm, is paying $10 million upfront and promising up to $60 million more in milestones in exchange for the exclusive commercial rights to the antibiotic solithromycin in Japan.
